05:46 PM EDT, 09/04/2025 (MT Newswires) -- Helen Torley, Director, President and CEO, on September 02, 2025, sold 60,000 shares in Halozyme Therapeutics ( HALO ) for $4,444,626. Following the Form 4 filing with the SEC, Torley has control over a total of 733,719 common shares of the company, with 733,719 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000141588925023720/xslF345X05/form4-09042025_090922.xml